Results

Total Results: 3,085 records

Showing results for "drug".

101. Final Report: Using Risk Models To Improve Safety With Dispensing High-Alert Medications in Community Pharmacies (pdf file)
     www.ahrq.gov/sites/default/files/2024-01/cohen-report.pdf
     January 01, 2024 - Scope and Significance Preventable Adverse Drug Events in Community Pharmacies Adverse drug events (ADEs … Fentanyl patch is classified by the Drug Enforcement Agency (DEA) as a Class II drug and, as such, requires … Incidence of adverse drug events and potential adverse drug events. Implications for prevention. … Serious adverse drug events reported to the Food and Drug Administration, 1998-2005. … Review of the Food and Drug Administration handling of adverse drug event reports.

102. Final Progress Report: UIC Center for Education and Research on Therapeutics Tools for Optimizing Prescribing, Monitoring and Education (TOP-MED) (pdf file)
     www.ahrq.gov/sites/default/files/2024-01/lambert2-report.pdf
     January 01, 2024 - Revitalize the drug formulary as an evidence-based tool for directing drug therapy decisions. 2. … The inter-drug module compares the rate of an AE for an individual drug with a background Poisson prediction … The Investigational Drug Service developed a support service to assist with drug study blinding and … Our Investigational Drug Service team has developed a support service model to assist with study drug … Drug Safety, 34(7): 533-544.

103. Event Investigation and Analysis Guide: Appendix A | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/capacity/candor/modules/guide4/apa.html
     February 01, 2017 - When the drug was brought into the facility, it was a different concentration from what had been used … There has been a drug shortage of the concentration that we typically use, and we had no choice but to … Our computer system is not connected to the National Drug Database, so we can’t simply scan the bottle … We have to enter every drug into our database manually. … In this case, the drug was entered as the wrong concentration.

104. Glossary | Agency for Healthcare Research and Quality
     www.ahrq.gov/questions/resources/glossary.html
     November 01, 2020 - Antibiotic: A drug used to treat infections caused by bacteria and other microorganisms. … Food and Drug Administration (FDA). … After the patent runs out on a brand-name drug, companies can apply to the FDA to make a generic copy … of that drug. … Side Effect: An effect of a drug, chemical, or other medicine that is in addition to its intended effect

105. Part 2: Trends in Priorities of the Heckler Report—Care for Substance Use Disorders | Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/nhqrdr/chartbooks/blackhealth/part2-subuse.html
     June 01, 2018 - Results from the 1983 single-room occupancy hotels study of drug abuse in New York City suggested that … Blacks had higher rates of drug use than Whites for marijuana, cocaine, heroin, and illicit methadone … drug use or an alcohol problem and who received such treatment at a specialty facility in the last 12 … Note: Treatment refers to treatment at a specialty facility, such as a drug and alcohol inpatient and … Overall Rate: In 2013, only 10.9% of people age 12 and over who needed treatment for illicit drug use

106. Clinicians and Their Chronically Ill Pediatric Patients Together Can Improve Medication Adherence and the Use of Health Care Services | Agency for Healthcare Research and Quality
     www.ahrq.gov/chain/practice-tools/drug-safety/medication-adherence.html
     March 01, 2017 - Clinicians and Their Chronically Ill Pediatric Patients Together Can Improve Medication Adherence and the Use of Health Care Services By Andrea Humphries, Ph.D. Download this information  (PDF, 576 KB) When children and adolescents with asthma, diabetes, epilepsy, or inflammatory bowel disease, or other chronic…

107. AHRQ Six Building Blocks: A Team-Based Approach to Improving Opioid Management in Primary Care | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/settings/ambulatory/improve/six-building-blocks.html
     March 01, 2022 - Blocks: A Team-Based Approach to Improving Opioid Management in Primary Care Deaths from drug … support for the 6BBs program came from the Washington State Department of Health, National Institute on Drug

108. Part 2: Trends in Priorities of the Heckler Report—Care for Substance Use Disorders | Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/nhqrdr/2014chartbooks/hispanichealth/part2-sbuse.html
     May 01, 2018 - Results from the 1983 single-room occupancy hotels study of drug abuse in New York City suggest that … Hispanics have higher rates of drug use than Whites for marijuana, cocaine, heroin, and illicit methadone … the last 12 months Same No Change People age 12 and over who needed treatment for illicit drug … Note: Treatment refers to treatment at a specialty facility, such as a drug and alcohol inpatient and … Overall Rate: In 2012, only 10.8% of people age 12 and over who needed treatment for illicit drug use

109. Final Progress Report: Risk Analysis of Pediatric Chemotherapy Processes (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/research/findings/final-reports/14295%20Shenep-draft-1.pdf
     June 01, 2005 - Calculate the drug dosage. … Likewise, if a mistake is found after the drug is dispensed, the drug is returned to the pharmacy … Visually verify that the drug in the bag matches the drug indicated on the label and order (e.g., confirm … Once in the prep area, double check the drug and drug concentration against the label. … , sound-alike drug name) RPN score: 70 15.2 Drug supplies past their expiration date used in preparation

110. AHRQ Signals Intent To Fund Clinics To Improve Care for People With Long COVID | Agency for Healthcare Research and Quality
     www.ahrq.gov/news/newsletters/e-newsletter/852.html
     February 01, 2023 - Physicians Should Consider Potential Drug Interactions When Prescribing Colchicine . … The AOP study examined clinical outcomes associated with colchicine drug interactions using reports … Food and Drug Administration’s Adverse Event Reporting System from January 2004 through June 2020. … It found a total of 787 reports that pointed to an adverse event from a colchicine drug interaction. … Both studies emphasized that colchicine drug interactions can almost always be prevented through proper

111. Final Progress Report: Show Your Work: Do Prescription Annotations Impact Near-miss Medication Errors? (pdf file)
     www.ahrq.gov/sites/default/files/2024-01/johnson-baughman-report.pdf
     January 01, 2024 - generating correct doses of prescriptions and medications; improving physician recognition of potential drug-drug … , drug- allergy, drug-food, or drug-indication reactions or contraindications; and improving compliance … FDB supports drug-allergy, drug-drug, drug-food, and drug-indication warnings as well as guidelines … Error-related callbacks Patient Instructions Contrary to Rx 15 2.98% Directions 55 10.91% Dosing 14 2.77% Drug-Drug … National Association of Chain Drug Stores; 1999. 18.

112. Optimizing Treatment Combinations in Individuals with Multiple Chronic Conditions (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/mcc/gagne-r01grant.pdf
     November 30, 2015 - 06/01/14--11/30/15 Grant Number: R01 HS023122-01 Description The clinical consequences of most drug-drug … clinical outcomes related to DDIs in patients with depression and other chronic conditions requiring drug … Modify existing semi-automated programs for rapid drug-drug interactions (DDI) assessment in electronic

113. Technology for Improving Medication Monitoring in Nursing Homes (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol4/Lapane.pdf
     March 09, 2005 - selection6–8 can lead to complications in drug therapy, often manifested as an adverse drug event ( … , whether the treatment includes an unsafe drug for the particular patient) … Are any conditions the result of drug therapy? … reaction Wrong drug; Dose too low Unnecessary drug therapy; Needs additional drug therapy … Incidence and preventability of adverse drug events in nursing homes.

114. Antibiotic Stewardship Program (ASP) Development
     www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/long-term-care/program-dev-slides.pptx
     June 01, 2021 - No monitoring for drug-drug interactions. No followup to narrow therapy. … No monitoring for drug-drug interactions. No followup to narrow therapy. … improvement The team chooses to focus on 2 post-prescriptive opportunities for improvement Monitor for drug-drug … No monitoring for drug-drug interactions. No followup to narrow therapy. … Developing a Program 14 Baseline Data Monitor for drug-drug interactions.

115. A Patient Safety Program & Research Evaluation of U.S. Navy Pharmacy Refill Clinics (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/Reige.pdf
     March 01, 2004 - The aim of this early program was improved monitoring of drug therapy, and patients with stable, drug … The program demonstrated that a pharmacist is capable of monitoring drug therapy. … This one case resulted in a drug-acquisition savings of $102.20 per year. … The resulting drug acquisition cost savings was $47.45 per year. … Percent of drug categories for Keflavik Pharmacy Refill Clinic Figure 4.

116. Final Progress Report: Advancing Patient Safety Innovation in Rheumatology (ASPIRE) (pdf file)
     www.ahrq.gov/sites/default/files/2024-02/yazdany-report.pdf
     January 01, 2024 - Food and Drug Administration Adverse Event Reporting System (FAERS). … Expert Opin Drug Saf. 2017;16(7):761-767. 3. Bourgeois FT, Shannon MW, Valim C, Mandl KD. … Adverse drug events in the outpatient setting: an 11-year national analysis. … Pharmacoepidemiology and drug safety. 2010;19(9):901-910. 4. Perrillo RP, Martin P, Lok AS. … Food and Drug Administration and Federal Trade Commission.

117. Novel Role for Adiponectin-enhancing Drugs for Asthma in the Obese (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/mcc/sood-r01grant.pdf
     January 31, 2016 - Potent adiponectin-enhancing drugs include the antidiabetic drug class of thiazolidinediones (TZD) and … antihypertensive drug class of angiotensin receptor blockers (ARB).

118. Study Recommends Training Community Pharmacists on Opioid Safety, Drug Monitoring Programs | Agency for Healthcare Research and Quality
     www.ahrq.gov/news/newsletter/e-newsletter/628.html
     August 01, 2018 - Study Recommends Training Community Pharmacists on Opioid Safety, Drug Monitoring Programs … Today's Headlines: Study Recommends Training Community Pharmacists on Opioid Safety, Drug Monitoring … Study Recommends Training Community Pharmacists on Opioid Safety, Drug Monitoring Programs Increased … The authors reviewed nearly a decade of published literature about prescription drug monitoring programs … Int J Drug Policy 2017 Aug;46:136-45. Epub 2017 Jun 1. Access the abstract on PubMed®.

119. Final Progress Report: Pharmacist Technology for Nursing Home Resident Safety (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/research/findings/final-reports/11835-Lapane-draft-1.pdf
     January 01, 2006 - Prospective drug regimen review: Current regulations require that the drug regimen of every nursing … The prevention of adverse drug events. ECPN 2005;June:26-32. Feinberg JL. … Approaches for optimisation of drug prescribing in elderly people. … Drug utilization in the US: 1986. … Incidence and preventability of adverse drug events in nursing homes.

120. AHRQ and National Institute on Drug Abuse Advocate for Research To Advance Equity in Substance Use Disorder Treatment | Agency for Healthcare Research and Quality
     www.ahrq.gov/news/newsletters/e-newsletter/819.html
     June 01, 2022 - AHRQ and National Institute on Drug Abuse Advocate for Research To Advance Equity in Substance Use Disorder … Today's Headlines: AHRQ and National Institute on Drug Abuse Advocate for Research To Advance Equity … AHRQ and National Institute on Drug Abuse Advocate for Research To Advance Equity in Substance Use Disorder … Experts from AHRQ and the National Institute on Drug Abuse (NIDA), along with NIDA’s director and AHRQ … include: Association of inappropriate outpatient pediatric antibiotic prescriptions with adverse drug